Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion-Reference-Cited by-同舟云学术

Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion

Published:2002-11-26 Issue:12 Volume:87 Page:1462-1469
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Thews O,Hummel M,Kelleher D K,Lecher B,Vaupel P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6600611.pdf

Reference47 articles.

1. Biaglow JE, Varnes ME, Jacobson B, Suit HD (1986) Effect of calcium channel blocking drugs on tumor cell oxygen utilization. Adv Exp Med Biol 200: 583–589

2. Bonen A, Clark MG, Henriksen EJ (1994) Experimental approaches in muscle metabolism: hindlimb perfusion and isolated muscle incubations. Am J Physiol 266: E1–E16

3. Cornwell MM, Pastan I, Gottesman MM (1987) Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166–2170

4. Creech O, Krementz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancers: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148: 616–631

5. de Wilt JH, Manusama ER, van Tiel ST, van Ijken MG, ten Hagen TL, Eggermont AM (1999) Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. Br J Cancer 80: 161–166

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symbiotic thermo-chemotherapy for enhanced HepG2 cancer treatment via magneto-drugs encapsulated polymeric nanocarriers;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2020-12

2. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection;International Journal of Molecular Sciences;2019-06-20

3. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery;Drug Resistance Updates;2007-06